Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

WHO Urges Pause On COVID-19 Booster Shots

Executive Summary

The pharmaceutical industry group, IFPMA, believes that a massive scale-up in manufacturing means booster shots will not necessarily “exacerbate inequities”.

You may also be interested in...



WHO Director General ‘Appalled’ At Industry Approach To COVID-19 Vaccines

World Health Organization director general says poorer countries should not have to be satisfied with richer country “left overs.”

UK Approves Booster Doses For Two COVID-19 Vaccines

AstraZeneca's Vaxzevria and Pfizer/BioNTech's vaccine can be used as "booster" vaccines in the UK, pending advice on a possible vaccination campaign from the government's advisory committee. 

EMA’s Emer Cooke On The Future Of Rolling Reviews & The End Of Remote Meetings

Emer Cooke, executive director of the European Medicines Agency, has offered some insights into how the agency’s working may change following the COVID-19 pandemic, including the development of hybrid inspections.

Topics

UsernamePublicRestriction

Register

PS144921

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel